Janssen to develop therapy for immunological diseases

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Singapore: Janssen Biotech has entered into a license agreement with Astellas Pharma for the worldwide development and c...Read more

European Commission nod for Novartis' Exjade

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 1 Comment | 26 Dec, 2012

Singapore: European Commission has approved Exjade (deferasirox) for the treatment of chronic iron overload requiring ch...Read more

CSL hemophilia therapy gets orphan drug status

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 1 Comment | 11 Jun, 2012

Singapore: CSL Behring's novel recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP...Read more

John Vernachio is Arthritis Foundation research VP

Drug Discovery |  Influencers | By BioSpectrum Bureau  | 3 Comment | 16 Apr, 2013

Singapore: Arthritis Foundation appointed Dr John Vernachio as vice president of research, effective April 15. In his ne...Read more

FDA gets biomarker database license from GVK Bio

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 2 Comment | 05 Feb, 2013

Singapore: GVK Biosciences is extending its Clinical Biomarker Database (Gobiom) license to the Biomarker Qualification ...Read more

Otsuka, Lundbeck files NDA for schizophrenia drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2014

Singapore: Japanese firm Otsuka Pharmaceutical and global firm H Lundbeck have submitted a New Drug Application (NDA) to...Read more

NIH study: Diabetes drug Metformin extends life

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

Singapore: Long-term treatment with the type 2 diabetes drug metformin improves health and longevity of male mice when s...Read more

Accelerating drug discovery process

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 26 Mar, 2012

In the last few years, biotech companies in Korea have targeted innovation in drug development and are building platform...Read more

Boehringer to open $46 mn biologics plant in Shanghai

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jun, 2013

Singapore: German drug major Boehringer Ingelheim has planned to build a biologics plant in Shanghai, China, to offer co...Read more

Recycled plastic can kill drug-resistant fungi

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 10 Dec, 2013

Singapore: Researchers at Singapore's Institute of Bioengineering and Nanotechnology (IBN) and California's IBM Research...Read more

Novartis liver cancer trial with Afinitor flops

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Aug, 2013

Singapore: Novartis highlighted that the results of a global phase III study showed that Afinitor (everolimus) did not e...Read more

Oramed submits pre-IND for exenatide to FDA

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 1 Comment | 02 Aug, 2013

Singapore: Oramed Pharmaceuticals, a developer of oral drug delivery systems, submitted a pre-Investigational New Drug (...Read more

Aussie drug delivery firm raises $19.3 mn

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2014

Singapore: Australian drug delivery company, Phosphagenics, has raised $19.3 million via a placement of $16.3 million to...Read more

Bayer initiates Phase II/III trial of a new compound for Hemophilia A

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Singapore, July 09, 2012: Bayer HealthCare has started to enroll patients in an international Phase II/III trial to eval...Read more

APAC ovarian cancer drug market to grow modestly'

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 3 Comment | 30 Jan, 2015

Singapore: Asia Pacific (APAC) therapeutics market for ovarian cancer will undergo a modest rise in value, from $294.3 m...Read more

Deal with Janssen gets Astellas $65 million up-front

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Oct, 2012

Singapore: Astellas Pharma signed a license agreement with Janssen Biotech under which Janssen has an exclusive right to...Read more

Lorcaserin receives positive vote from FDA advisory committee

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Singapore: Eisai announced that the US Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory C...Read more

Biodiem gets US patent allowance for antifungal therapy

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Singapore: Australian infectious disease therapy and vaccine development company BioDiem has received notice of Allowanc...Read more